Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
When Myeloma Escapes the Bone Marrow: Extramedullary Disease in the Immunotherapy Era.
Journal: Cancers
Published: June 28, 2026
Association of genetic ancestry with outcomes and toxicity of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma.
Journal: Blood cancer journal
Published: October 31, 2025
Analysis of Social Drivers of Health, Race, and Ethnicity With Survival in Myeloma Patients.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 28, 2025
EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer.
Journal: Cancers
Published: March 04, 2024
The Great Masquerader: Syphilis Mimicking Papilledema and Traction Alopecia.
Journal: Cureus
Published: April 28, 2020
EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells.
Journal: Molecular cancer therapeutics
Published: September 03, 2019
EMP2 is a novel therapeutic target for endometrial cancer stem cells.
Journal: Oncogene
Published: January 06, 2016
Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma.
Journal: The Journal of biological chemistry
Published: March 20, 2014
Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure.
Journal: Molecular cancer
Published: June 24, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026